Estrogen Supplementation Mode in HRT-FET Cycle: a RCT

Status Not yet recruiting

Clinical Trial Summary

A systematic review and meta-analysis concluded that there is insufficient evidence to recommend one particular protocol for HRT with regard to pregnancy rates after frozen embryo transfer, and no comparison of estrogen dose or route of administration was included in the review[7]. It is worth highlighting that the authors did not find any literature discussing the effect of estrogen dose and route of administration for HRT on reproductive outcomes. In 2016, a retrospective cohort study concluded that there is no difference in live birth rates between a constant dose versus an increasing dose of estrogen in oocyte donation cycles with oral or transdermal supplementation[6]. In order to provide good evidence about pattern of estrogen supplementation in HRT-FET, a randomized controlled study is urgently needed.

The present randomized controlled study aims to compare between a constant estrogen dose protocol and a step-wise increasing estrogen dose protocol on the live birth rate of HRT-FET cycles.

Clinical Trial Description

The objective is to compare between a constant estrogen dose protocol and a step-wise increasing estrogen dose protocol on live birth rate of HRT-FET cycles.

This is a multicenter randomized controlled trial. Women undergoing HRT-FET will be recruited and randomized to use a constant estrogen dose protocol and a step-wise increasing estrogen dose protocol.

Participation in the study is totally voluntary. The subjects can withdraw from the study at any time and they will still receive standard medical care.

Women being scheduled for HRT-FET will be assessed for eligibility. Eligible women will be recruited in the study and each woman will only be included in the study once.

Informed written consent will be obtained prior to recruitment. The baseline characteristics will be collected. Transvaginal ultrasound will be done to measure the endometrial thickness on the day of progesterone supplementation. Embryo transfer will be performed 3 days or 5 days after progesterone use, depending on replacement of cleaving stage embryos or blastocysts respectively. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04503915
Study type	Interventional
Source	Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Contact	Haiyan Lin
Phone	15913154456
Email	709235159@qq.com
Status	Not yet recruiting
Phase	N/A
Start date	November 1, 2020
Completion date	December 1, 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04742816` - Renal Effects of Hormones/Biomarkers in Transgender PrEP Recipients	Phase 4
Recruiting	`NCT04453332` - Effects of Hormone Replacement Therapy on Cardiovascular Risk and Body Composition Parameters	N/A
Recruiting	`NCT06353555` - Efficacy of Thyroid Hormone Replacement for Secondary Hypothyroidism Following Intracerebral Hemorrhage	N/A
Active, not recruiting	`NCT04758871` - Oral Versus Vaginal Progesterone for Luteal Phase Supplementation in Frozen Embryo Transfer Cycles	Phase 4
Recruiting	`NCT00785317` - Effects of Estradiol on Menopausal Breast	Phase 4
Completed	`NCT00463450` - Efficacy of Gynodian® Depot in Women With Impaired Well-being	Phase 3
Completed	`NCT00319072` - Hormone Replacement Therapy (HRT) Website Tool	Phase 2
Recruiting	`NCT05166083` - Investigation of the Perceptual and Acoustic Voice in Trans Man
Completed	`NCT05774405` - Short-term Effects of Transdermal Estradiol on Female COVID-19 Patients	Phase 2
Completed	`NCT01023802` - The Use of Molecular Breast Imaging in the Evaluation of Tumor Response to Neoadjuvant Therapy in Women With Breast Cancer	N/A
Completed	`NCT01070979` - Hormone Replacement Therapy for Use in Postmenopausal Women for Relief of Hot Flushes and Urogenital Symptoms.	Phase 3
Not yet recruiting	`NCT05122065` - Menopausal Vaginal Microbiome
Withdrawn	`NCT05168865` - Letrozole Versus Hormonal Preparation in Frozen Cycles of PCOS Patients.	Phase 4
Completed	`NCT05072756` - Opinion of Brazilian Gynecologists on Hormone Therapy for Menopause and Prescriptive Habits
Not yet recruiting	`NCT06372119` - Letrozole-stimulated Cycle Strategy Versus Artificial Cycle Strategy (LETSACT)	N/A
Not yet recruiting	`NCT06357442` - Assessment of Endometrial Thickness Among Adolescent and Young Adult Patients on Estrogen Replacement Therapy Using Daily Oral Micronized Progesterone Versus the Etonogestrel Implant.
Recruiting	`NCT04478760` - Trans & Non-binary Reference Intervals While on Hormone Therapy Study
Completed	`NCT00012909` - Development and Evaluation of a Hormone Replacement Therapy Decision-Aid	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.